Rare diseases
Investigational molecules
Locations
Back to Spain60 clinical trials in Ferrol, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)SpainA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
SpainA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
SpainStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
SpainStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
SpainEfficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
SpainRandomized trial of elecoglipron with dapagliflozin versus placebo in adults with type 2 diabetes mellitus and impaired renal function
SpainA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
SpainDermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma
SpainRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
SpainA study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication
SpainN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
SpainThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for Type 2 Diabetes and obesity management. Studies evaluate new insulin formulations and novel therapeutic approaches for weight management.
Multiple trials exploring dual-action medications targeting both obesity and associated conditions.
Comprehensive research into inflammatory bowel conditions, including Ulcerative Colitis and Crohn's Disease. Studies focus on novel therapeutic agents and treatment approaches.
Innovative therapies being evaluated for both induction and maintenance of remission.
Studies targeting cardiovascular disease prevention and treatment, including research on stroke prevention in atrial fibrillation and atherosclerosis management.
Focus on both preventive measures and therapeutic interventions for various cardiac conditions.
Investigation of treatments for chronic kidney disease, including both diabetic and non-diabetic conditions. Research evaluates novel therapeutic combinations and standalone treatments.
Emphasis on delaying disease progression and improving outcomes in kidney disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
